Myovant Sciences Announces Financial Results for Second Quarter of Fiscal Year 2021 and Corporate Updates

NEXT STORY
FibroGen to Report Third Quarter 2021 Financial Results
PREV STORY
Half-year report and dividend declaration
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global $8.4 Bn Ultrasound Market Analysis & Forecast to 2023: Opportunities in Expanding Applications of Therapeutic Ultrasound, Emerging Markets & Advent of POC Ultrasound Devices

author_avatar
NASDAQ Market News

The global microbial identification panel market is expected to reach US$ 3,873.1 Mn in 2027 from US$ 2,288.7 Mn in 2018

author_avatar
NASDAQ Market News

Rexahn Pharmaceuticals Presents Clinical Data for Three Novel Targeted Oncology Programs at the 2016 American Society of Clinical Oncology Annual Meeting

ROCKVILLE, Md., June 06, 2016 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a ...

author_avatar
NASDAQ Market News